Scientists at The Scripps Research Institute have discovered a new aspect of the flu virus and how it interacts with antibodies in the lungs.
The Skaggs Graduate School of Chemical and Biological Sciences at The Scripps Research Institute is ranked among the top ten in the nation according to a recent survey by U.S. News & World Report.
TSRI scientists investigate a phenomenon that may guard against disease as we age.
The breakthrough may expand research on the roles of glycans in human diseases, including cancers.
These new areas of interest belong to the so-called “non-coding” genome–the 98 percent of the genome that doesn’t directly code for proteins but instead regulates how key proteins are produced.
Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.
Scientists often struggle to predict how these cells will act in different environments in the body.
The findings point the way to targeting diseases where this protein is mutated.
“Eric is an esteemed colleague with a clear vision for integrating scientific discovery and translational medicine.”
A new study from The Scripps Research Institute (TSRI) is the first to show precisely how a process in nerve cells called the S-nitrosylation (SNO) reaction–which can be caused by aging, pesticides and pollution–may contribute to Parkinson’s disease.
NitroSynapsin is intended to restore an electrical signaling imbalance in the brain found in virtually all forms of autism spectrum disorder (ASD).
Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod. Ozanimod was invented by scientists at The Scripps Research Institute (TSRI).
Egg-based production causes virus to target bird cells, making vaccine less effective.
Scientists from the Florida campus of The Scripps Research Institute have created a new class of antibody-drug conjugates for cancer therapy.
A prominent and inventive chemical biologist, Cravatt’s research focuses on the role proteins play in cellular processes.
Chemists at The Scripps Research Institute (TSRI) have demonstrate that they can repurpose DNA to create new substances with possible medical applications.